These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 17116317)

  • 1. Susceptibility groups for Alzheimer's disease (OPTIMA cohort): integration of gene variants and biochemical factors.
    Corder EH; Beaumont H
    Mech Ageing Dev; 2007 Jan; 128(1):76-82. PubMed ID: 17116317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic risk profiles for Alzheimer's disease: integration of APOE genotype and variants that up-regulate inflammation.
    Licastro F; Porcellini E; Caruso C; Lio D; Corder EH
    Neurobiol Aging; 2007 Nov; 28(11):1637-43. PubMed ID: 16930778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sharing pathogenetic mechanisms between acute myocardial infarction and Alzheimer's disease as shown by partially overlapping of gene variant profiles.
    Licastro F; Chiappelli M; Caldarera CM; Porcellini E; Carbone I; Caruso C; Lio D; Corder EH
    J Alzheimers Dis; 2011; 23(3):421-31. PubMed ID: 21098980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relations between homocysteine, folate and vitamin B12 in vascular dementia and in Alzheimer disease.
    Köseoglu E; Karaman Y
    Clin Biochem; 2007 Aug; 40(12):859-63. PubMed ID: 17532313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic susceptibility sets for Alzheimer's disease identified from diverse candidate loci.
    Corder EH; Blennow K; Prince JA
    Rejuvenation Res; 2008 Jun; 11(3):667-79. PubMed ID: 18593285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic risk factors and markers for Alzheimer's disease and/or depression in the VITA study.
    Grünblatt E; Zehetmayer S; Bartl J; Löffler C; Wichart I; Rainer MK; Jungwirth S; Bauer P; Danielczyk W; Tragl KH; Riederer P; Fischer P
    J Psychiatr Res; 2009 Jan; 43(3):298-308. PubMed ID: 18603262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute myocardial infarction and proinflammatory gene variants.
    Licastro F; Chiapelli M; Caldarera CM; Caruso C; Lio D; Corder EH
    Ann N Y Acad Sci; 2007 Nov; 1119():227-42. PubMed ID: 18056971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High plasma homocysteine is associated with the risk of coronary artery disease independent of methylenetetrahydrofolate reductase 677C-->T genotypes.
    Lin PT; Huang MC; Lee BJ; Cheng CH; Tsai TP; Huang YC
    Asia Pac J Clin Nutr; 2008; 17(2):330-8. PubMed ID: 18586656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma folate and total homocysteine levels are associated with the risk of myocardial infarction, independently of each other and of renal function.
    Van Guelpen B; Hultdin J; Johansson I; Witthöft C; Weinehall L; Eliasson M; Hallmans G; Palmqvist R; Jansson JH; Winkvist A
    J Intern Med; 2009 Aug; 266(2):182-95. PubMed ID: 19298497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Butyrylcholinesterase, ApoE and Alzheimer's disease in a population from the Canary Islands (Spain).
    Déniz-Naranjo MC; Muñoz-Fernández C; Alemany-Rodríguez MJ; del Carmen Pérez-Vieitez M; Aladro-Benito Y; Irurita-Latasa J; Sánchez-García F
    Neurosci Lett; 2007 Oct; 427(1):34-8. PubMed ID: 17923322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association study of MICA and MICB in Alzheimer's disease.
    Quiroga I; Lehmann DJ; Barnardo MC; Fuggle S; Cortina-Borja M; Warden DR; Smith AD
    Tissue Antigens; 2009 Sep; 74(3):241-3. PubMed ID: 19691640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of the Pro12Ala polymorphism of PPAR-gamma on age at onset and sRAGE levels in Alzheimer's disease.
    Yao L; Li K; Zhang L; Yao S; Piao Z; Song L
    Brain Res; 2009 Sep; 1291():133-9. PubMed ID: 19631630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
    Lane R; Feldman HH; Meyer J; He Y; Ferris SH; Nordberg A; Darreh-Shori T; Soininen H; Pirttilä T; Farlow MR; Sfikas N; Ballard C; Greig NH
    Pharmacogenet Genomics; 2008 Apr; 18(4):289-98. PubMed ID: 18334913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin converting enzyme insertion/deletion polymorphism in sporadic and familial Alzheimer's disease and longevity.
    Nacmias B; Bagnoli S; Tedde A; Cellini E; Bessi V; Guarnieri B; Ortensi L; Piacentini S; Bracco L; Sorbi S
    Arch Gerontol Geriatr; 2007; 45(2):201-6. PubMed ID: 17182125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between the APOE epsilon4 allele and the APH-1b c + 651T > G SNP in Alzheimer's disease.
    Poli M; Gatta LB; Lovati C; Mariani C; Galimberti D; Scarpini E; Biunno I; Musicco M; Dominici R; Albertini A; Finazzi D
    Neurobiol Aging; 2008 Oct; 29(10):1494-501. PubMed ID: 17466415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vitamin B status and cognitive performance in preclinical and clinical Alzheimer's disease: data from the Kungsholmen Project.
    Wahlin A; Fahlander K; Wahlin TB; Bunce D; Bäckman L
    Dement Geriatr Cogn Disord; 2008; 25(1):23-31. PubMed ID: 18025826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomised double-blind placebo-controlled trial of folic acid supplementation of cholinesterase inhibitors in Alzheimer's disease.
    Connelly PJ; Prentice NP; Cousland G; Bonham J
    Int J Geriatr Psychiatry; 2008 Feb; 23(2):155-60. PubMed ID: 17600848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of SORL1 gene variants with Alzheimer's disease.
    Kölsch H; Jessen F; Wiltfang J; Lewczuk P; Dichgans M; Teipel SJ; Kornhuber J; Frölich L; Heuser I; Peters O; Wiese B; Kaduszkiewicz H; van den Bussche H; Hüll M; Kurz A; Rüther E; Henn FA; Maier W
    Brain Res; 2009 Apr; 1264():1-6. PubMed ID: 19368828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.
    Borroni B; Archetti S; Costanzi C; Grassi M; Ferrari M; Radeghieri A; Caimi L; Caltagirone C; Di Luca M; Padovani A;
    Neurobiol Aging; 2009 Sep; 30(9):1406-12. PubMed ID: 18179845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CDC2 I-G-T haplotype associated with the APOE epsilon4 allele increases the risk of sporadic Alzheimer's disease in Sicily.
    Bosco P; Caraci F; Copani A; Spada RS; Sortino MA; Salluzzo R; Salemi M; Nicoletti F; Ferri R
    Neurosci Lett; 2007 Jun; 419(3):195-8. PubMed ID: 17498878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.